AMI Received Pfizer’s Top Supplier Service Award

AMI is honored to once again receive a Pfizer Partner Excellence Award in recognition of AMI’s valued partnership with Pfizer Global Commercial Operations.

This award recognizes AMI’s ongoing commitment to performance and partnership excellence with world-renowned pharmaceutical and biotechnology company Pfizer, specifically as part of the Digital Communications area in the HCP and Patient Engagement Center.

Pfizer is a leading research-based biopharmaceutical company applying their global resources to deliver innovative therapies that extend and improve lives. Pfizer’s vital work advances wellness, prevention, treatments, and cures that challenge the major diseases of today. Notably, they are responsible for creating one of the life-saving COVID-19 vaccinations, currently used worldwide in the fight against the worst pandemic in living memory.

 “AMI’s partnership with Pfizer has grown year over year and the hard work has once again paid off!”, said Pip Macfarlane, Vice President of Client Service for the Pfizer-AMI partnership. “We are so lucky to work with such a world-class organization solving some of the world’s biggest health issues, including COVID-19.”

Find out more about Pfizer here.